Article Versions Notes

Ou Y, You Z, Yao M, Cao Y, Xue X, Chen M, Wu R, Gan L, Li D, Wu P, et al. Naproxen-Derived New Compound Inhibits the NF-κB, MAPK and PI3K/Akt Signaling Pathways Synergistically with Resveratrol in RAW264.7 Cells. Molecules. 2023; 28(8):3395. https://doi.org/10.3390/molecules28083395

Ou, Yi, Zonglin You, Min Yao, Yingfan Cao, Xiu Xue, Min Chen, Rihui Wu, Lishe Gan, Dongli Li, Panpan Wu, and et al. 2023. "Naproxen-Derived New Compound Inhibits the NF-κB, MAPK and PI3K/Akt Signaling Pathways Synergistically with Resveratrol in RAW264.7 Cells" Molecules 28, no. 8: 3395. https://doi.org/10.3390/molecules28083395

Ou, Y., You, Z., Yao, M., Cao, Y., Xue, X., Chen, M., Wu, R., Gan, L., Li, D., Wu, P., Xu, X., Wong, W., Wong, V. K. W., Liu, W., Ye, J., & Jin, J. (2023). Naproxen-Derived New Compound Inhibits the NF-κB, MAPK and PI3K/Akt Signaling Pathways Synergistically with Resveratrol in RAW264.7 Cells. Molecules, 28(8), 3395. https://doi.org/10.3390/molecules28083395